TAT-11: Consideration toward Safety Guidance for Targeted Alpha Therapy in Japan

Prof. Yano described evaluation standard for non-clinical studies necessary for first-in-human TAT studies in Japan. He emphasized the steps for determining the initial safe dose and protocols for increasing the dose. PET or SPECT scans using complementary imaging agents is important for establishing the biodistribution both for targeting efficiency and protection of other organs.

Alpha cameras are useful for measuring the microdose. Japan Atomic Energy Agency is developing a micro-dosimetric simulation package.

Presented by: Professor Tsuneo Yano, Osaka University, RCNP, Suita, Japan

Written by: William Carithers, Lawrence Berkeley National Laboratory at the 11th International Symposium on Targeted Alpha Therapy (TAT-10)  April 1 - April 4, 2019 - Ottawa, ON, Canada

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.